These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 7584664)

  • 1. A monoclonal antibody to the NH2-terminal region of human interferon-gamma inhibits its antiproliferative activity without affecting its internalization.
    Folghera S; Caruso A; Fiorentini S; Rusnati M; Gao J; Gargiulo F; Balsari A; Turano A
    J Interferon Cytokine Res; 1995 Mar; 15(3):197-204. PubMed ID: 7584664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A monoclonal antibody to the NH2-terminal segment of human IFN-gamma selectively interferes with the antiproliferative activity of the lymphokine.
    Caruso A; Tiberio L; De Rango C; Bonfanti C; Flamminio G; Gribaudo G; Monti E; Viani E; Manca N; Garotta G
    J Immunol; 1993 Feb; 150(3):1029-35. PubMed ID: 8423329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural immuno-analysis of human and porcine interferon gamma: identification of shared antigenic domain.
    Kontsek P; Martens E; Vandenbroeck K; Kontseková E; Waschütza G; Sareneva T; Billiau A
    Cytokine; 1997 Aug; 9(8):550-5. PubMed ID: 9245481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a domain of a human type I interferon receptor protein involved in ligand binding.
    Eid P; Tovey MG
    J Interferon Cytokine Res; 1995 Mar; 15(3):205-11. PubMed ID: 7584665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A monoclonal antibody to recombinant human IFN-alpha receptor inhibits biologic activity of several species of human IFN-alpha, IFN-beta, and IFN-omega. Detection of heterogeneity of the cellular type I IFN receptor.
    Benoit P; Maguire D; Plavec I; Kocher H; Tovey M; Meyer F
    J Immunol; 1993 Feb; 150(3):707-16. PubMed ID: 8423335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibodies to human interferon-gamma. II: Antibodies with neutralizing activity.
    Ichimori Y; Suzuki N; Kitada C; Tsukamoto K
    Hybridoma; 1987 Apr; 6(2):173-81. PubMed ID: 2437010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycosylation of the human interferon-gamma receptor. N-linked carbohydrates contribute to structural heterogeneity and are required for ligand binding.
    Fischer T; Thoma B; Scheurich P; Pfizenmaier K
    J Biol Chem; 1990 Jan; 265(3):1710-7. PubMed ID: 2136857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of residues involved in ligand binding and signal transmission in the human IFN-alpha receptor 2.
    Chuntharapai A; Gibbs V; Lu J; Ow A; Marsters S; Ashkenazi A; De Vos A; Jin Kim K
    J Immunol; 1999 Jul; 163(2):766-73. PubMed ID: 10395669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibodies neutralizing the antiviral and the antiproliferative activities of human interferon gamma.
    Kontsek P; Borecký L; Kontseková E; Sujanová Z; Novák M
    Acta Virol; 1988 Jul; 32(4):334-8. PubMed ID: 2903638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection against natural killer cells by interferon-gamma treatment of K562 cells cannot be explained by augmented major histocompatibility complex class I expression.
    Nishimura M; Mitsunaga S; Akaza T; Mitomi Y; Tadokoro K; Juji T
    Immunology; 1994 Sep; 83(1):75-80. PubMed ID: 7821970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspects of molecular interaction between HIV p17 and human gamma interferon.
    Flamminio G; Caruso A; Poiesi C; Bonfanti C; Terlenghi L; Donato Canaris A; Varinacci C; Martinelli F; Garotta G; Albertini A
    AIDS Res Hum Retroviruses; 1995 Dec; 11(12):1441-7. PubMed ID: 8679287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutralizing epitopes on the extracellular interferon gamma receptor (IFNgammaR) alpha-chain characterized by homolog scanning mutagenesis and X-ray crystal structure of the A6 fab-IFNgammaR1-108 complex.
    Sogabe S; Stuart F; Henke C; Bridges A; Williams G; Birch A; Winkler FK; Robinson JA
    J Mol Biol; 1997 Nov; 273(4):882-97. PubMed ID: 9367779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of interferon-beta in combination with 5-fluorouracil on the growth of esophageal cancer cells in vitro.
    Tsunoo H; Komura S; Ohishi N; Akiyama S; Kasai Y; Ito K; Nakao A; Yagi K
    Anticancer Res; 2001; 21(5):3301-6. PubMed ID: 11848487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human interleukin 4 receptor complex: neutralization effect of two monoclonal antibodies.
    Taremi SS; Prosise WW; Rajan N; O'Donnell RA; Le HV
    Biochemistry; 1996 Feb; 35(7):2322-31. PubMed ID: 8652573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of horse polyclonal antiserum inhibiting all in vitro biological functions of human IFN-gamma.
    Martinelli F; Licenziati S; Garrafa E; Signorini C; Caruso A; Turano A
    J Biol Regul Homeost Agents; 1998; 12(4):112-8. PubMed ID: 10022002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding and cross-linking of recombinant mouse interferon-gamma to receptors in mouse leukemic L1210 cells; interferon-gamma internalization and receptor down-regulation.
    Wietzerbin J; Gaudelet C; Aguet M; Falcoff E
    J Immunol; 1986 Apr; 136(7):2451-5. PubMed ID: 2936825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct functional domains on the recombinant human immune interferon molecule.
    Ziai MR; Imberti L; Kobayashi M; Perussia B; Trinchieri G; Ferrone S
    Cancer Res; 1986 Dec; 46(12 Pt 1):6187-90. PubMed ID: 3096556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human interferon-gamma has three domains associated with its antiviral function: a neutralizing epitope typing scheme for human interferon-gamma.
    Kwok AY; Zu X; Yang C; Alfa MJ; Jay FT
    Immunology; 1993 May; 79(1):131-7. PubMed ID: 7685313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attachment of LcrV from Yersinia pestis at dual binding sites to human TLR-2 and human IFN-gamma receptor.
    Abramov VM; Khlebnikov VS; Vasiliev AM; Kosarev IV; Vasilenko RN; Kulikova NL; Khodyakova AV; Evstigneev VI; Uversky VN; Motin VL; Smirnov GB; Brubaker RR
    J Proteome Res; 2007 Jun; 6(6):2222-31. PubMed ID: 17441749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interferon-gamma receptor extracellular domain. Non-identical requirements for ligand binding and signaling.
    Axelrod A; Gibbs VC; Goeddel DV
    J Biol Chem; 1994 Jun; 269(22):15533-9. PubMed ID: 8195198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.